Balshi A, Dempsey JP, Manning N, Leuenberger G, et al. Malignant melanoma and multiple sclerosis therapies: A disproportionality analysis of the FDA adverse event reporting system. Mult Scler 2025 Jun 25:13524585251342725. doi: 10.1177/13524585251342725.
PMID: 40566642